Response to sorafenib treatment in advanced metastatic thyroid cancer.
about
Selective use of sorafenib in the treatment of thyroid cancerPartial response to sorafenib treatment associated with transient grade 3 thrombocytopenia in a patient with locally advanced thyroid cancer.New therapies for dedifferentiated papillary thyroid cancerSorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma.
P2860
Response to sorafenib treatment in advanced metastatic thyroid cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@en
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@nl
type
label
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@en
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@nl
prefLabel
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@en
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@nl
P2860
P1476
Response to sorafenib treatment in advanced metastatic thyroid cancer.
@en
P2093
Fabian Pitoia
P2860
P356
10.1590/0004-2730000002839
P577
2014-02-01T00:00:00Z